Prevalence of Acute Hypersensitivity Reactions in Pediatric Patients Receiving Crotalidae Polyvalent Immune Fab

Bryan Corbett1, Jenna Otter2, Clifford P Masom3

  • 1Division of Medical Toxicology, Department of Emergency Medicine, UC San Diego Health, 200 West Arbor Drive #8676, San Diego, CA, 92103, USA. bcorbett@health.ucsd.edu.

Insights

Acute hypersensitivity reactions to Crotalidae Polyvalent Immune Fab (CPIF) were not observed in pediatric patients. This study indicates that such adverse events are rare in children treated for snakebites.

Area of Science:

  • Pediatric Toxicology
  • Pharmacovigilance
  • Allergy and Immunology

Background:

  • Acute hypersensitivity reactions to Crotalidae Polyvalent Immune Fab (CPIF) pose a challenge in pediatric populations due to variations in patient size, age, and reaction definitions.
  • Understanding the incidence of these reactions is crucial for safe and effective treatment of Crotalid envenomation in children.

Purpose of the Study:

  • To evaluate the occurrence of acute hypersensitivity reactions following CPIF administration in pediatric patients.
  • To define and assess the incidence of specific hypersensitivity symptoms within a defined timeframe after CPIF initiation.

Main Methods:

  • A retrospective chart review was conducted on pediatric patients (≤13 years) treated with CPIF for Crotalid envenomation between November 2006 and 2016.
  • Data collected included demographics, CPIF dosage, bite details, ICU admission, length of stay, and the presence of hypersensitivity symptoms (urticaria, respiratory distress, angioedema, hypotension, nausea, vomiting) within 3 hours of infusion.

Main Results:

  • Thirty-four pediatric patients received CPIF, with ages ranging from 10 months to 13 years.
  • No patients in this cohort developed acute hypersensitivity reactions to CPIF.
  • The majority of patients (70.6%) required intensive care unit admission, with a median hospital stay of 2 days.

Conclusions:

  • Acute hypersensitivity reactions to CPIF were not observed in this cohort of pediatric patients.
  • The findings suggest that CPIF is well-tolerated in children, with hypersensitivity reactions being a rare occurrence.
Abstract

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
5.7K
Allergic Reactions02:06

Allergic Reactions

Overview
31.6K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Cross-reactivity00:42

Cross-reactivity

Overview
32.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
148
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131